GlobeNewswire

Xenon to Report Q3 2026 Financial Results on November 9, 2026
02/11/2026
VANCOUVER, BC and BOSTON, MA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and [...]
Assembly Biosciences to Participate in Upcoming Investor Conferences
02/11/2026
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today [...]
Avalo Therapeutics to Participate in Upcoming Investor Conferences
02/11/2026
WAYNE, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated [...]
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
02/11/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following [...]
Coloplast A/S Announcement no. 11/2026 - 2025/26 Full-Year Financial Results
02/11/2026
1 October 2025 - 30 September 2026 Coloplast delivered 5% organic growth in Q4, driven by continued strength in Chronic Care and Interventional Urology. EBIT growth 1 in constant currencies was 0% and includes negative [...]
Coloplast A/S Announcement no. 10/2026 - Coloplast announces revised financial ambition towards 2030 and FY 2026/27 guidance
02/11/2026
Announcement no. 10/2026 Inside information Revised financial ambition towards 2030 includes 5-7% organic growth per year and an EBIT margin 1 in constant currencies in the mid-20% range over the period. Return on [...]
Z Optics Receives Approval to Expand European Clinical Study of the Z+ Virtual Aperture IOL to Canada
02/11/2026
Following exceptional feedback from patients and physicians in Europe, the clinical trial of the Virtual Aperture intraocular lens will now open to clinical sites and patients in Canada RENO, Nev., Nov. 02, 2026 (GLOBE [...]
NeOnc Is Putting Two Brain Cancer Programs on the Global Stage
02/11/2026
Two Clinical Programs, a 500-Patient Vision, and a November that Could Be a Game-Changer for the Growing Wall Street Story DENVER, Nov. 02, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews.com ) — In a market where the latest [...]
Quiet Communities Launches Free Science-based Resource Hub to Help Communities Address Data Center Noise
02/11/2026
Downloadable materials translate public health research and acoustical expertise into practical guidance for addressing noise throughout data center planning, construction and operation LINCOLN, Mass., Nov. 02, 2026 ( [...]
Transactions under Novonesis’ share buyback program
02/11/2026
Please read the announcement in PDF Attachment 2026_26_Share_buyback
Pamela Anderson announced as keynote speaker for BC Women’s Health Foundation’s 2027 Illuminations Luncheon
02/11/2026
The B.C.-born actress, author, philanthropist and mother will return home for a candid conversation about transformation, reinvention, aging and women’s health this International Women’s Day VANCOUVER, British Columbia [...]
Family-Run Protocol Health Brings Its Physician-Led Care Nationwide Through Protocol MD, Offering GLP-1 Weight Loss, Peptide Therapy and Bloodwork Online in All 50 States
02/11/2026
Founded by cousins Dr. Richard Dentico, a board-certified physiatrist, and Joe Garvey, the Scarsdale, New York practice extends the care it built in person to patients nationwide, from the first assessment through every [...]
AnewHealth Announces Strategic Growth Investments from Linden Capital Partners and Nautic Partners
02/11/2026
Leading healthcare investors with deep pharmacy expertise partner with AnewHealth to accelerate clinical innovation and expand individualized care for people with complex medical needs. MOORESTOWN, N.J., Nov. 02, 2026 ( [...]
Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader
02/11/2026
Merger positions Supernus as a leading diversified central nervous system (CNS) biopharmaceutical company with a broad portfolio of marketed medicines, enhanced financial flexibility and a differentiated pipeline [...]
Eikon Therapeutics to Participate in Multiple Investor Conferences in November
02/11/2026
CEO Roger M. Perlmutter, M.D., Ph.D., to participate in G uggenheim 3 rd Annual Healthcare Innovation Conference Fireside Chat and JP Morgan Biotech Call series CMO Roy Baynes, M.D., Ph.D., to participate in Morgan [...]
LifeWorks Wellness Center Welcomes Community to New Treatment Facility
02/11/2026
CLEARWATER, Fla., Nov. 02, 2026 (GLOBE NEWSWIRE) -- LifeWorks Wellness Center marked the official opening of its new treatment facility with a ribbon-cutting ceremony on October 22. Over 100 guests gathered for the [...]
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2026 Financial Results on November 6, 2026
02/11/2026
FREDERICK, Md., Nov. 02, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions today announced it will report results for the third [...]
BioVie Selected for Late-Breaking Oral Presentation of Bezisterim Long COVID Data at the 4th Long COVID International Conference 2026
02/11/2026
CARSON CITY, Nev., Nov. 02, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases [...]
Compass Therapeutics to Participate in Upcoming November Investor Events
02/11/2026
BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum